APLS Apellis Pharmaceuticals

Apellis Pharmaceuticals to Host Conference Call on May 7, 2025, to Discuss First Quarter 2025 Financial Results

Apellis Pharmaceuticals to Host Conference Call on May 7, 2025, to Discuss First Quarter 2025 Financial Results

WALTHAM, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- , Inc. (Nasdaq: APLS) today announced that the company will host a conference call and webcast to discuss its first quarter 2025 financial results on Wednesday, May 7, 2025, at 8:30 a.m. ET.

To access the live call by phone, please pre-register for the call . A live audio webcast of the event and accompanying slides may also be accessed through the “Events and Presentations” page of the “Investors and Media” section of the company’s . A replay of the webcast will be available for 90 days following the event.

About Apellis 

Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two approved medicines targeting C3. These include the first-ever therapy for geographic atrophy, a leading cause of blindness around the world. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases. For more information, please visit or follow us on and .

Investor Contact:

Neil Carnahan



207.318.4494



EN
30/04/2025

Underlying

APLSApellis Pharmaceuticals

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Apellis Pharmaceuticals

 PRESS RELEASE
Free
APLS Apellis Pharmac...

Apellis Pharmaceuticals to Host Conference Call on May 7, 2025, to Dis...

Apellis Pharmaceuticals to Host Conference Call on May 7, 2025, to Discuss First Quarter 2025 Financial Results WALTHAM, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- , Inc. (Nasdaq: APLS) today announced that the company will host a conference call and webcast to discuss its first quarter 2025 financial results on Wednesday, May 7, 2025, at 8:30 a.m. ET. To access the live call by phone, please pre-register for the call . A live audio webcast of the event and accompanying slides may also be accessed through the “Events and Presentations” page of the “Investors and Media” section of the comp...

17h / 40m 1 EN
 PRESS RELEASE
Free
APLS Apellis Pharmac...

Apellis Announces Craig Wheeler to Join the Board of Directors

Apellis Announces Craig Wheeler to Join the Board of Directors WALTHAM, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that Craig Wheeler, founder and chief executive officer of Headwaters Biotech Advisors, will join the Apellis Board of Directors, effective immediately. Mr. Wheeler is a highly accomplished executive with more than 30 years of leadership experience across the biopharmaceutical industry. “We are thrilled to welcome Craig to the Apellis Board of Directors,” said Cedric Francois, M.D., Ph.D., chief executive officer ...

April 21, 2025 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 43.95
IEX IDEX CORPORATIO...
TXN Texas Instrumen... ... (+39)

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

IEX IDEX CORPORATION
TXN TEXAS INSTRUMENTS INCORPORATED
TRN TRINITY INDUSTRIES INC.
THRM GENTHERM INCORPORATED
TER TERADYNE INC.
SLAB SILICON LABORATORIES INC.
SCL STEPAN COMPANY
ROG ROGERS CORPORATION
ROCK GIBRALTAR INDUSTRIES INC.
RBC REGAL BELOIT CORP
PCAR PACCAR INC
MGPI MGP INGREDIENTS INC.
LFUS LITTELFUSE INC.
LEN LENNAR CORPORATION CLASS A
KWR QUAKER CHEMICAL CORPORATION
IOSP INNOSPEC INC.
CGNX COGNEX CORPORATION
CCS CENTURY COMMUNITIES INC.
BZH BEAZER HOMES USA INC.
BCC BOISE CASCADE CO.
AOSL ALPHA & OMEGA SEMICONDUCTOR
AMPH AMPHASTAR PHARMACEUTICALS INC
ALB ALBEMARLE CORPORATION
MHK MOHAWK INDUSTRIES INC.
MG/CN MAGNA INTERNATIONAL INC.
BC BRUNSWICK CORPORATION
AMWD AMERICAN WOODMARK CORPORATION
LPX LOUISIANA-PACIFIC CORPORATION
MLHR HERMAN MILLER INC.
NX QUANEX BUILDING PRODUCTS CORPORATION
TNC TENNANT COMPANY
SITE SITEONE LANDSCAPE SUPPLY INC.
ICHR ICHOR HOLDINGS LTD.
APLS APELLIS PHARMACEUTICALS
YETI YETI HOLDINGS
HLIO HELIOS TECHNOLOGIES INC.
MBC_w MASTERBRAND INC
ZK ZEEKR INTELLIGENT TECHNOLOGY HOLDING LIMITED
TE ALUSSA ENERGY ACQUISITION CORP
04/17/25 April 17, 2025 1 EN
Wedbush Research
  • Wedbush Research
KMX CARMAX INC.
XNCR XENCOR INC.
WDC WESTERN DIGITAL CORPORATION
TSLA TESLA INC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SAGE SAGE THERAPEUTICS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
BPMC BLUEPRINT MEDICINES CORP.
BIIB BIOGEN INC.
BCRX BIOCRYST PHARMACEUTICALS INC.
AXTI AXT INC.
ARDX ARDELYX INC
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
TSEM TOWER SEMICONDUCTOR LTD
KNSA KINIKSA PHARMACEUTICALS
TVTX TRAVERE THERAPEUTICS INC
CGEM CULLINAN ONCOLOGY INC
STX SEAGATE TECHNOLOGY HLDGS PLC
GFS GLOBALFOUNDRIES INC
ARTV ARTIVA BIOTHERAPEUTICS INC
SYRE SPYRE THERAPEUTICS INC.
04/16/25 April 16, 2025 1 EN
Dylan Shindler ... (+2)
  • Dylan Shindler
  • Laura Chico
SAGE SAGE THERAPEUTICS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
NBIX NEUROCRINE BIOSCIENCES INC.
BIIB BIOGEN INC.
BCRX BIOCRYST PHARMACEUTICALS INC.
ARDX ARDELYX INC
APLS APELLIS PHARMACEUTICALS
TVTX TRAVERE THERAPEUTICS INC
04/16/25 April 16, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch